News
Johnson & Johnson must pay more than $42 million to a Massachusetts man who alleges that he developed mesothelioma, a rare ...
A $42 million verdict on Tuesday in Boston is the latest for a plaintiff alleging Johnson & Johnson’s baby powder caused ...
Johnson & Johnson (NYSE:JNJ) ranks among the stocks to benefit from an onshoring boom. On July 23, Erste Group raised the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results